Evidence map›Paper›PMID 40486961›Full record

ArticleExploration of targeted anti-tumor therapy2025

Mutational landscape of epidermoid carcinoma of the penis in a Brazilian cohort.

Renato Mendes Rossi De Lucca, Danielle Barbosa Brotto, Claudia Tarcila Gomes Sares, Kelly Gomes Duarte, Wilson Araujo Silva Junior, Philippe E Spiess, Shahrokh F Shariat, Natália Dalsenter Avilez, Caio de Oliveira, Leonardo O Reis and 1 more

Abstract read
In one paragraph

Article in Exploration of targeted anti-tumor therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Renato Mendes Rossi De LuccaMedicine School of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14040-900, Brazil.
Danielle Barbosa BrottoMedicine School of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14040-900, Brazil.
Claudia Tarcila Gomes SaresMedicine School of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14040-900, Brazil.
Kelly Gomes DuarteMedicine School of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14040-900, Brazil.
Wilson Araujo Silva JuniorMedicine School of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14040-900, Brazil.
Philippe E SpiessMorsani College of Medicine, Moffitt Cancer Center, University of South Florida, Tampa, FL 33612, USA.
Shahrokh F ShariatINCT UroGen, National Institute of Science, Technology and Innovation in Genitourinary Cancer (INCT), Campinas 13087-571, Brazil.
Natália Dalsenter AvilezINCT UroGen, National Institute of Science, Technology and Innovation in Genitourinary Cancer (INCT), Campinas 13087-571, Brazil.
Caio de OliveiraINCT UroGen, National Institute of Science, Technology and Innovation in Genitourinary Cancer (INCT), Campinas 13087-571, Brazil.
Leonardo O ReisINCT UroGen, National Institute of Science, Technology and Innovation in Genitourinary Cancer (INCT), Campinas 13087-571, Brazil.ORCID https://orcid.org/0000-0003-2092-414X
Rodolfo Borges Dos ReisMedicine School of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14040-900, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: Penile cancer (PeCa) is a rare malignancy strongly associated with poor genital hygiene and is more prevalent in regions with low socioeconomic status. PeCa accounts for approximately 2% to 4% of all male cancers in Brazil, with higher incidence in the North and Northeast regions. Despite its aggressive nature, the molecular mechanisms underlying PeCa remain poorly understood. We performed whole-exome sequencing in a Brazilian cohort of patients with PeCa to identify potentially pathogenic genetic alterations associated with tumor development and progression. Methods: Tumor tissue samples were obtained from patients diagnosed with PeCa. DNA was extracted and subjected to whole-exome sequencing. Human papillomavirus (HPV) genotyping was performed for subtypes 16 and 18. Control samples were collected from individuals without PeCa or other genital diseases. Results: The cohort demonstrated considerable genetic heterogeneity. Multiple gene mutations were identified in tumor samples, many of which are involved in carcinogenesis-related biological pathways. Distinct molecular profiles were observed, suggesting diverse tumorigenic mechanisms. Conclusions: This study provides new insights into the genomic landscape of PeCa in a Brazilian population. The findings highlight the presence of heterogeneous and potentially pathogenic mutations, reinforcing the need for further molecular characterization and exploration of novel therapeutic targets in PeCa.

Indexed as

epidemiologymutationsPenile cancer

Identifiers

PMID40486961
PMCPMC12142355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.